ScHARR-TAG has been allocated the following topic as part of the NICE Technolgy Appraisal Programme:
TK cell therapy following haploidentical haematopoietic stem cell transplant for adults with acute leukaemia.
The draft scope is here and the provisional stakeholder matrix here.